Predictive role of CD36 expression in HER2-positive breast cancer patients receiving neoadjuvant trastuzumab. Ligorio F, Di Cosimo S, Verderio P, Ciniselli CM, et al. J Natl Cancer Inst 2022 Jul 5. pii: 6631230. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Ligorio F, Di Cosimo S, Verderio P, Ciniselli CM, et al. Predictive role of CD36 expression in HER2-positive breast cancer patients receiving neoadjuvant trastuzumab. J Natl Cancer Inst 2022 Jul 5. pii: 6631230. doi: 10.1093.
PMID: 35789270